Top-down Infliximab Study in Kids With Crohn's Disease
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2019
Price : $35 *
At a glance
- Drugs Infliximab (Primary) ; Azathioprine; Prednisolone
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms TISKids
- 06 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated
- 08 Feb 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.